Breast cancer is the most commonly diagnosed cancer in women, and it is crucial for women of all ages to understand their risk factors and take proactive steps towards breast health. Regular breast self-examinations, clinical breast examinations, and mammograms can aid in the early detection of breast cancer, improving treatment outcomes and survival rates.
Breast cancer is a type of cancer that begins in the cells of the breast. According to the World Health Organization (WHO), breast cancer is the most common cancer among women worldwide, with an estimated 2.3 million new cases diagnosed in 2020. It is the fifth leading cause of death from cancer in women, with an estimated 685,000 deaths in 2020. According to the American Cancer Society, in the United States, it’s estimated that about 1 in 8 women (about 13%) will develop invasive breast cancer in their lifetime.
Breast cancer in men is rare, but it can occur. Globally, the incidence of breast cancer in men is less than 1% of all breast cancer cases. However, it’s important for men to be aware of the signs and symptoms of breast cancer and to seek medical attention if they notice any changes in their breast tissue.
The incidence of breast cancer varies widely by country and region. In developed countries, the incidence is higher than in developing countries, although the mortality rate is lower due to early detection and better treatment options.
Breast cancer can be detected through various methods, including mammograms, clinical breast exams, and breast self-exams. Common symptoms of breast cancer include a lump or thickening in the breast or underarm, changes in breast size or shape, nipple discharge or tenderness, and changes in the texture or appearance of the skin over the breast.
It is crucial to do regular breast self-exams. By performing a breast self-exam regularly, women become familiar with the normal look and feel of their breasts, which can help them detect any changes or abnormalities early on. Early detection of breast cancer is associated with better treatment outcomes and a higher chance of survival.
It’s important to note that breast self-exam should not be used as the only method for breast cancer screening, and women should also undergo regular mammography and clinical breast exams as recommended by their healthcare provider.
Immucura is deeply concerned about the early detection of breast cancer and this is why Immucura is actively investing in research and development to create innovative solutions that can detect breast cancer at an early stage. Early detection of breast cancer is crucial for successful treatment and recovery. The earlier the cancer is detected, the higher the chance of successful treatment and recovery.
Immucura offers a comprehensive cancer screening program which includes a range of advanced tests and services to detect breast cancer in its early stages, you can know more about it in this link:
Treatment for breast cancer can include surgery, radiation therapy, chemotherapy, targeted therapy, and hormone therapy, depending on the stage and type of cancer. Dendritic cell therapy is a type of immunotherapy that is being investigated as a potential treatment for breast cancer. Dendritic cell therapy can help stimulate the patient’s immune system to recognize and attack cancer cells. By presenting tumor antigens to the immune system, dendritic cells can help activate T cells, which are specialized immune cells that can kill cancer cells.
Dendritic cell therapy can be customized to target the patient’s specific type of breast cancer, which may increase its effectiveness compared to other treatments that are not targeted. Because dendritic cell therapy can stimulate the immune system to recognize and remember cancer cells, there is a potential for long-term protection against the cancer, even after the treatment has ended.
Immucura offers this Dendritic Cell Therapy which is natural and non-invasive and precisely because it is natural, it can be combined with other cancer treatments at the same time. Immucura has been working on this Dendritic Cell Therapy with cancer patients for many years and most of them have been breast cancer cases. Thanks to all the information available today about DCT, this non-invasive treatment is becoming more and more known worldwide.
Immucura’s patient testimonials are helping other cancer patients to learn about this therapy and its high success rate like Michele’s story: “I was first diagnosed with breast cancer in 2016. In the beginning of 2019 another lump was found and I only had between 6 to 9 months to live. I attended the appointment with a man called Doctor Ramon Simon-Lopez and he was offering Dendritic Cell Therapy with a company called Immucura.
Immucura and the whole team has been absolutely amazing. With conventional treatments and conventional hospitals you have your appointment and then you’re gone, and nobody really speaks to you or calls you or texts you. With everyone at Immucura there on the phone, constantly doing anything I need, any clues any questions and you don’t have to chase for answers or chase for any solutions. You know that they are coming up with solutions all the time. And they genuinely care, so I would really recommend them. “